Interleukin-36 Receptor Antagonist class drugs

1 result

Spevigo (spesolimab-sbzo)

(spesolimab-sbzo)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients aged 12 and older, who weigh at least 40 kg.